# Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic Ulcers

> **NCT07708545** · PHASE2 · RECRUITING · sponsor: **Universitas Indonesia** · enrollment: 162 (estimated)

## Conditions studied

- Peptic Ulcer Bleeding

## Interventions

- **DRUG:** Tegoprazan tablet
- **DRUG:** Lansoprazole capsules

## Key facts

- **NCT ID:** NCT07708545
- **Lead sponsor:** Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-06
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2026-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07708545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07708545, "Tegoprazan Versus Lansoprazole for Endoscopic Ulcer Healing in Bleeding Peptic Ulcers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07708545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*